Inui K, Morimoto T, Komaki K, Sonoo H, Monden Y
Second Department of Surgery, School of Medicine, University of Tokushima, Japan.
Jpn J Surg. 1988 May;18(3):284-90. doi: 10.1007/BF02471445.
Tamoxifen was administered over a period of 4 weeks to 19 female Sprague-Dawley rats bearing 20 DMBA-induced mammary tumors. Consequently, 13 tumors (65.0 per cent) regressed and showed a reduction in their estradiol receptor (ER) and progesterone receptor (PgR) concentrations. In spite of subsequent treatment given to the rats bearing the regressed tumors, 6 new tumors occurred. The ER and PgR concentrations of these tumors were lower than those of the tumors before tamoxifen therapy, and histochemical study showed these tumors to be composed mostly of ER-negative cells. These results suggest that: (a) the hormone dependency of breast cancer is reduced by tamoxifen therapy; (b) breast cancers recurring during tamoxifen therapy show reduced hormone dependency.
对19只患有20个二甲基苯并蒽诱导乳腺肿瘤的雌性斯普拉格-道利大鼠,在4周的时间内给予他莫昔芬治疗。结果,13个肿瘤(65.0%)消退,其雌二醇受体(ER)和孕酮受体(PgR)浓度降低。尽管对患有消退肿瘤的大鼠进行了后续治疗,但仍出现了6个新肿瘤。这些肿瘤的ER和PgR浓度低于他莫昔芬治疗前肿瘤的浓度,组织化学研究表明这些肿瘤主要由ER阴性细胞组成。这些结果表明:(a)他莫昔芬治疗可降低乳腺癌的激素依赖性;(b)他莫昔芬治疗期间复发的乳腺癌显示激素依赖性降低。